This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...
Investors often find that companies with a history of increasing dividends perform better than those without. When a company’s management announces a dividend increase,...
Medtronic (NYSE:MDT) reported its Q4 fiscal year 2023 earnings on Thursday. The numbers looked strong at first glance, with both earnings and revenues topping...
Introduction As an investor in dividend growth companies, I always seek new investment opportunities in income-producing assets. I usually add to my existing positions...
Roche Holding AG (OTCQX:RHHBY, OTCPK:RHHVF, OTCQX:RHHBF) is a good long-term biotech to own. That’s because it already has received FDA approval for its multiple...